New hope to stop repeat strokes: safer drug trial launches
NCT ID NCT07180472
Summary
This study compares three blood-thinning medications to see which works best at preventing repeat strokes in people with cerebral small vessel disease. Researchers will randomly assign 632 participants who recently had a small stroke to take either cilostazol, aspirin, or clopidogrel. They'll track whether patients have another stroke, if their thinking abilities decline, and monitor safety over time to find the most effective treatment with the fewest side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL SMALL VESSEL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.